XML 121 R41.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock Incentives (Tables)
12 Months Ended
Jun. 29, 2014
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]  
Schedule of Assumptions Used to Determine Fair Value
The assumptions used to determine fair value are as follows:
Options Granted During
 
2014
 
2013
 
2012
Grant Date Fair Value
 
$
5.19

 
$
4.83

 
$
3.96

(Since options are only granted once per year, the grant date fair value equals the weighted average grant date fair value.)
 
 
 
 
 
 
Assumptions:
 
 
 
 
 
 
Risk-free Interest Rate
 
1.6
%
 
0.7
%
 
1.0
%
Expected Volatility
 
41.3
%
 
43.9
%
 
43.2
%
Expected Dividend Yield
 
2.5
%
 
2.6
%
 
3.0
%
Expected Term (in Years)
 
5.0

 
5.0

 
5.0

Schedule of Options Outstanding
Information on the options outstanding is as follows:
 
 
Options
 
Wtd. Avg. Exercise Price
 
 Wtd. Avg. Remaining Contractual Term (in years)
 
Aggregate Intrinsic Value (in thousands)
Balance, July 3, 2011
 
4,721,190

 
$
26.38

 
 
 
 
Granted During the Year
 
465,350

 
16.20

 
 
 
 
Exercised During the Year
 
(15,870
)
 
14.83

 
 
 
 
Expired During the Year
 
(474,240
)
 
29.87

 
 
 
 
Balance, July 1, 2012
 
4,696,430

 
$
25.06

 
 
 
 
Granted During the Year
 
399,850

 
18.85

 
 
 
 
Exercised During the Year
 
(1,151,882
)
 
17.37

 
 
 
 
Expired During the Year
 
(573,130
)
 
30.81

 
 
 
 
Balance, June 30, 2013
 
3,371,268

 
$
25.97

 
 
 
 
Granted During the Year
 
407,860

 
20.82

 
 
 
 
Exercised During the Year
 
(273,394
)
 
19.76

 
 
 
 
Expired During the Year
 
(1,088,368
)
 
32.82

 
 
 
 
Balance, June 29, 2014
 
2,417,366

 
$
22.71

 
1.91
 
$
2,795

Exercisable, June 29, 2014
 
1,165,016

 
$
27.19

 
0.57
 
$
139

Schedule of Options Grants Outstanding Summary
Options Outstanding (as of June 29, 2014)
Fiscal
Year
 
Grant
Date
 
Date
Exercisable
 
Expiration
Date
 
Exercise
Price
 
Options
Outstanding
2005
 
8/13/2004
 
8/13/2007
 
8/13/2014
 
$
36.68

 
508,260

2010
 
8/18/2009
 
8/18/2012
 
8/31/2014
 
$
19.73

 
159,696

2011
 
8/17/2010
 
8/17/2013
 
8/31/2015
 
$
19.88

 
497,060

2012
 
8/16/2011
 
8/16/2014
 
8/31/2016
 
$
16.20

 
444,640

2013
 
8/14/2012
 
8/14/2015
 
8/31/2017
 
$
18.85

 
399,850

2014
 
8/20/2013
 
8/20/2016
 
8/31/2018
 
$
20.82

 
407,860

Summary of Nonvested Shares
Below is a summary of the status of the Company’s nonvested shares as of June 29, 2014, and changes during the year then ended:
 
 
Deferred Stock
 
Restricted Stock
 
Stock Options
 
Performance Shares
 
 
Shares
 
Wtd. Avg.
Grant Date
Fair Value
 
Shares
 
Wtd. Avg.
Grant Date
Fair Value
 
Shares
 
Wtd. Avg.
Grant Date
Fair Value
 
Shares
 
Wtd. Avg.
Grant Date
Fair Value
Nonvested shares,
June 30, 2013
 
567,943

 
$
17.05

 
820,597

 
$
17.12

 
1,391,550

 
$
3.97

 
249,170

 
$
18.59

Granted
 
64,553

 
19.48

 
146,320

 
19.28

 
407,860

 
5.19

 
128,371

 
19.09

Cancelled
 

 

 
(9,386
)
 
17.51

 

 

 
(13,040
)
 
18.60

Vested
 
(206,978
)
 
14.48

 
(109,771
)
 
13.51

 
(547,060
)
 
5.24

 

 

Nonvested shares,
June 29, 2014
 
425,518

 
$
18.67

 
847,760

 
$
17.96

 
1,252,350

 
$
4.64

 
364,501

 
$
18.77

Performance Share Assumptions Used in Monte Carlo Simulation
Assumptions used in the Monte Carlo valuation model include the following:
Performance Shares Granted During
 
2014
 
2013
 
2012
Assumptions:
 
 
 
 
 
 
Risk-free Interest Rate
 
0.7
%
 
0.4
%
 
0.3
%
Expected Volatility
 
32.1
%
 
35.5
%
 
46.0
%
Expected Dividend Yield (Dividends are Assumed Reinvested)
 
%
 
%
 
%
Expected Term (in Years)
 
2.86

 
2.87

 
2.87

Schedule of Stock-Based Compensation Programs
The following table summarizes the components of the Company’s stock-based compensation programs recorded as expense:
 
 
2014
 
2013
 
2012
Stock Options:
 
 
 
 
 
 
Pretax compensation expense
 
$
2,065

 
$
1,964

 
$
1,760

Tax benefit
 
(791
)
 
(766
)
 
(686
)
Stock option expense, net of tax
 
$
1,274

 
$
1,198

 
$
1,074

Restricted Stock:
 
 
 
 
 
 
Pretax compensation expense
 
$
2,563

 
$
2,375

 
$
2,102

Tax benefit
 
(982
)
 
(926
)
 
(820
)
Restricted stock expense, net of tax
 
$
1,581

 
$
1,449

 
$
1,282

Deferred Stock:
 
 
 
 
 
 
Pretax compensation expense
 
$
685

 
$
475

 
$
534

Tax benefit
 
(252
)
 
(185
)
 
(208
)
Deferred stock expense, net of tax
 
$
433

 
$
290

 
$
326

Performance Shares:
 
 
 
 
 
 
Pretax compensation expense
 
$
1,861

 
$
1,700

 
$
1,159

Tax benefit
 
(713
)
 
(664
)
 
(452
)
Performance Share expense, net of tax
 
$
1,148

 
$
1,036

 
$
707

Total Stock-Based Compensation:
 
 
 
 
 
 
Pretax compensation expense
 
$
7,174

 
$
6,514

 
$
5,555

Tax benefit
 
(2,738
)
 
(2,541
)
 
(2,166
)
Total stock-based compensation, net of tax
 
$
4,436

 
$
3,973

 
$
3,389